Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
Andrea Cipriani(Oxford Health NHS Foundation Trust), John Geddes(University of Oxford), Nozomi Takeshima(Kyoto University), Aran Tajika(Kyoto University), Hissei Imai(Kyoto University), Erick H. Turner(Oregon Health & Science University), Julian P. T. Higgins(University of Bristol), Lauren Atkinson(Warneford Hospital), Kiyomi Shinohara(Kyoto University), Yu Hayasaka(Kyoto University), John P. A. Ioannidis(Innovative Research (United States)), Matthias Egger(University of Zurich), Toshi A. Furukawa(Kyoto University), Georgia Salanti(University of Bern), Anna Chaimani(Inserm), Stefan Leucht(TUM Klinikum), Henricus G. Ruhé(Radboud University Nijmegen), Yusuke Ogawa(Kyoto University)
Cited by 342
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Genome-wide association studies for complex traits: consensus, uncertainty and challenges
|Nature Reviews Genetics|2008|3k